Piramal Initiates Phase II Trial of Diabetes Drug

by Kathy Jones on  September 20, 2010 at 8:30 PM Clinical Trials News   - G J E 4
One of India's leading pharmaceutical companies, Piramal Life Sciences has announced that it has started the phase-II study into its upcoming diabetic drug.
 Piramal Initiates Phase II Trial of Diabetes Drug
Piramal Initiates Phase II Trial of Diabetes Drug

The company's Managing Director Somesh Sharma revealed that the phase-II study of 'P1736-05' has been started and the company was confident of a successful completion of the study.

The P1736-05 is an insulin sensitizing compound which will be a part of the company's new drug for the treatment of type-2 diabetes in India and Europe.

"The commencement of phase-II trial of P1736-05 in India and Europe speaks of our efforts to build a diversified and strong pipeline of products to address unmet medical needs. P1736-05 is likely to provide a safe and effective therapeutic option to type-2 diabetic patients", Sharma added.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like